MedTrace Logo

Comparative Efficacy of Two Preparations of the Association Diosmin (450 mg) + Hesperidin (50 mg) in the Treatment of Chronic Venous Insufficiency (CVI)

NCT01110512 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2010-10-27

No results posted yet for this study

Summary

It is hoped that with the use of medication, occurs improvement of the CVI parameters, such as edema, pain, night cramps, functional discomfort, heavy feeling and that the drug test is non-inferior than the comparator.

Conditions

  • Venous Insufficiency

Interventions

DRUG

Flavonid

Diosmin (450 mg) + hesperidin (50 mg) 1 tablet, 2 times per day.

DRUG

Daflon

Diosmin (450 mg) + hesperidin (50 mg) 1 tablet, 2 times per day

Sponsors & Collaborators

  • Azidus Brasil

    lead INDUSTRY

Principal Investigators

  • Alexandre Frederico, Doctor · LAL Clinical Reseach e Development Ltda

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2010-12-31
Completion
2011-03-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01110512 on ClinicalTrials.gov